Horsthuis D, Molholm S, Foxe J, Francisco A
Orphanet J Rare Dis. 2023; 18(1):389.
PMID: 38087330
PMC: 10714457.
DOI: 10.1186/s13023-023-02985-y.
Servais A, Boisgontier J, Saitovitch A, Hummel A, Boddaert N
Cells. 2022; 11(4).
PMID: 35203331
PMC: 8870159.
DOI: 10.3390/cells11040682.
Francisco A, Berruti A, Kaskel F, Foxe J, Molholm S
Orphanet J Rare Dis. 2021; 16(1):177.
PMID: 33849633
PMC: 8045394.
DOI: 10.1186/s13023-021-01818-0.
Midgley J, El-Kares R, Mathieu F, Goodyer P
Pediatr Nephrol. 2011; 26(8):1335-7.
PMID: 21553323
DOI: 10.1007/s00467-011-1904-z.
Spilkin A, Ballantyne A, Trauner D
Neuropsychologia. 2009; 47(8-9):1883-92.
PMID: 19428420
PMC: 2700001.
DOI: 10.1016/j.neuropsychologia.2009.02.032.
Nephropathic cystinosis: late complications of a multisystemic disease.
Nesterova G, Gahl W
Pediatr Nephrol. 2007; 23(6):863-78.
PMID: 18008091
DOI: 10.1007/s00467-007-0650-8.
Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.
Tsilou E, Zhou M, Gahl W, Sieving P, Chan C
Surv Ophthalmol. 2007; 52(1):97-105.
PMID: 17212992
PMC: 1850966.
DOI: 10.1016/j.survophthal.2006.10.006.
Early oral cysteamine therapy for nephropathic cystinosis.
Gahl W
Eur J Pediatr. 2003; 162 Suppl 1:S38-41.
PMID: 14610675
DOI: 10.1007/s00431-003-1349-x.
Osteopenia and fractures in cystinotic children post renal transplantation.
Zimakas P, Sharma A, Rodd C
Pediatr Nephrol. 2003; 18(4):384-90.
PMID: 12700967
DOI: 10.1007/s00467-003-1093-5.
A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.
Tsilou E, Thompson D, Lindblad A, Reed G, Rubin B, Gahl W
Br J Ophthalmol. 2002; 87(1):28-31.
PMID: 12488257
PMC: 1771471.
DOI: 10.1136/bjo.87.1.28.
The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region.
Phornphutkul C, Anikster Y, Huizing M, Braun P, Brodie C, Chou J
Am J Hum Genet. 2001; 69(4):712-21.
PMID: 11505338
PMC: 1226058.
DOI: 10.1086/323484.
The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion.
Touchman J, Anikster Y, Dietrich N, Maduro V, McDowell G, Shotelersuk V
Genome Res. 2000; 10(2):165-73.
PMID: 10673275
PMC: 310836.
DOI: 10.1101/gr.10.2.165.
Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.
Grody W, Kern R, Klein D, DODSON A, Wissman P, Barsky S
Hum Genet. 1993; 91(1):1-5.
PMID: 8454280
DOI: 10.1007/BF00230212.
Growth and pubertal development in nephropathic cystinosis.
Winkler L, Offner G, Krull F, BRODEHL J
Eur J Pediatr. 1993; 152(3):244-9.
PMID: 8444253
DOI: 10.1007/BF01956154.
Hemiparesis in a girl with cystinosis and renal transplant.
Van Lierde A, Colombo D, Rossi L, Marchesi F, Giani M, Consalvo G
Eur J Pediatr. 1994; 153(9):702-3.
PMID: 7957435
DOI: 10.1007/BF02190698.
Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.
Gahl W, Schneider J, Schulman J, Thoene J, Reed G
Pediatr Nephrol. 1990; 4(2):129-35.
PMID: 2397178
DOI: 10.1007/BF00858823.
Update on nephropathic cystinosis.
Schneider J, Katz B, Melles R
Pediatr Nephrol. 1990; 4(6):645-53.
PMID: 2088469
DOI: 10.1007/BF00858644.
Effects of oral phosphocysteamine and rectal cysteamine in cystinosis.
vant Hoff W, Baker T, Dalton R, Duke L, Smith S, Chantler C
Arch Dis Child. 1991; 66(12):1434-7.
PMID: 1776892
PMC: 1793392.
DOI: 10.1136/adc.66.12.1434.
Renal transplantation in 22 children with nephropathic cystinosis.
Ehrich J, BRODEHL J, Byrd D, Hossfeld S, Hoyer P, Leipert K
Pediatr Nephrol. 1991; 5(6):708-14.
PMID: 1768583
DOI: 10.1007/BF00857880.